Categoria: Articoli in lingua originale

For Patients with Newly Diagnosed Type 2 Diabetes, Metformin Is the Best First Choice

Initial metformin yielded a lower likelihood of needing a second agent compared with other drug classes. Metformin is recommended by several organizations and guidelines as first-line therapy in patients with newly diagnosed type 2 diabetes, but clinicians often start with other classes of hypoglycemics. In this retrospective cohort study, researchers

Continua a leggere

Abbott Receives CE Mark for FreeStyle® Libre, a Revolutionary Glucose Monitoring System for People with Diabetes

ABBOTT PARK, Ill., Sept. 3, 2014 — Abbott today announced that it has received CE Mark (Conformité Européenne) for its FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes. The system eliminates the need for routine finger pricks1, reading glucose levels through a

Continua a leggere

Islet cell transplantation provided healing effect for neuropathy

Islet cell transplantation may have a healing effect for patients with diabetic neuropathy, according to ongoing study data presented at the American Diabetes Association’s 74th Scientific Sessions. As of November 2013, David M.Thompson, MD, clinical assistant professor and medical director of the Vancouver Islet Transplant Program in Vancouver, British Columbia, and

Continua a leggere

Do Specific DSM Disorders Increase the Risk for Diabetes?

In a 19-country, community-based survey, adult-onset diabetes mellitus was associated with increased rates of prior depression, impulse control disorders, and two eating disorders. Patients with complications of diabetes mellitus have elevated rates of mood and cognitive disorders. Concomitantly, some psychiatric disorders might be associated with increased risk for subsequent diabetes.

Continua a leggere

Longer-Term Follow-Up from a Bariatric Surgery Trial for Diabetic Patients

At 3 years, glycemic control and quality of life were better with surgery than with medical management. In a previously published report from a randomized Cleveland Clinic trial, Roux-en-Y gastric bypass and sleeve gastrectomy were more likely than medical therapy (42% and 37% vs. 12%) to lower glycosylated hemoglobin (HbA1c)

Continua a leggere
Skip to content